Skip to NavigationSkip to content

News

0
Indian flag against a setting sun
India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 fatalities officially confirmed.
0
MHRA sign
The MHRA has approved Astellas Pharma’s XTANDI (enzalutamide) drug for the treatment of a third form of prostate cancer, making it the only oral...
0
NICE has published final guidance today which rejects tafamidis, also known as Vyndaqel, for treating rare heart condition transthyretin amyloidosis...
0
Endogena Therapeutics Inc has been granted Orphan Drug Designation for its EA-2353 ophthalmic suspension targeting retinitis pigmentosa by the FDA.

Features

The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new...